Members of the serine/threonine protein phosphatase 2 A (PP2A) family of tumor suppressors are frequently inactivated in human cancers, and negatively modulate numerous oncogenic pathways in neoplasia [3–5]. The gene discussed is PTPA; the disease is neoplasm.